Takeda, Astellas, Eisai Forecast 10 Percent-Plus Drop In Foreign Sales
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical, Astellas Pharma and Eisai, Japan's three largest drug makers, expect a decline of about 10 percent each in foreign sales in the year that began April 1